Atypical Reye syndrome: three cases of a problem that pediatricians should consider and remember

Serena Ferretti1, Antonio Gatto2, Antonietta Curatola3

  • 1Department of Woman and Child Health and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy. serena.ferretti01@icatt.it.

Insights

Reye syndrome is a rare metabolic disorder in children, often following viral infections. This study highlights atypical cases, emphasizing diagnostic challenges and the need for increased awareness in pediatric critical care.

Area of Science:

  • Pediatric critical care medicine
  • Metabolic disorders
  • Neurology

Background:

  • Reye syndrome is a rare acquired metabolic disorder in children, typically following viral infections.
  • Its pathogenesis involves mitochondrial dysfunction leading to liver and brain issues.
  • Clinical presentation includes vomiting, liver dysfunction, and acute encephalopathy.

Purpose of the Study:

  • To describe three cases of Reye syndrome with atypical features.
  • To highlight diagnostic challenges and increase awareness of the condition.
  • To analyze factors influencing prognosis and treatment.

Main Methods:

  • Case report analysis of three children with Reye syndrome.
  • Review of clinical features, laboratory findings, and neurological examinations.
  • Assessment of diagnostic criteria and therapeutic interventions.

Main Results:

  • Three cases presented with atypical features, including no intake of trigger substances and transient hematological changes.
  • Observed dissociation between hepatic dysfunction, severe EEG changes, and mild neurological impairment.
  • Metabolic acidosis was consistently detected, but diagnostic criteria remain non-specific.

Conclusions:

  • Reye syndrome diagnosis can be challenging, particularly in atypical presentations.
  • Increased awareness and understanding of these variations are crucial for timely diagnosis and management.
  • Prognosis depends on disease stage and promptness of intensive care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
53
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
62
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
84
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
71
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K